StockData
Zeo ScientifiX, Inc. logo

Zeo ScientifiX, Inc. (ZEOX) stock

ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q2 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.91+0.00 (+0.15%)

Close on Oct 19, 2026Market cap $7.08MP/E –Yield –

Zeo ScientifiX ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Zeo ScientifiX's ebitda for the twelve months ending Apr 30, 2026 was -$4.05M. For fiscal 2025 it was -$5.31M. The highest annual figure on record is -$5.25M in fiscal 2024.

Annual ebitda

PeriodPeriod endValueChange
FY2025Oct 31, 2025-$5.31M–
FY2024Oct 31, 2024-$5.25M–
FY2023Oct 31, 2023-$6.28M–
FY2022Oct 31, 2022-$8.51M–
FY2021Oct 31, 2021-$12.69M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ1 2026Apr 30, 2026-$493.00K–
Q1 FY2026CQ4 2025Jan 31, 2026-$859.00K–
Q4 FY2025CQ3 2025Oct 31, 2025-$648.00K–
Q3 FY2025CQ2 2025Jul 31, 2025-$2.05M–
Q2 FY2025CQ1 2025Apr 30, 2025-$1.38M–
Q1 FY2025CQ4 2024Jan 31, 2025-$1.24M–
Q2 FY2024CQ1 2024Apr 30, 2024-$1.55M–
Q1 FY2024CQ4 2023Jan 31, 2024-$1.14M–
Q4 FY2023CQ3 2023Oct 31, 2023-$1.22M–
Q3 FY2023CQ2 2023Jul 31, 2023-$1.29M–
Q4 FY2022CQ3 2022Oct 31, 2022-$2.92M–
Q3 FY2022CQ2 2022Jul 31, 2022-$2.73M–
Q2 FY2022CQ1 2022Apr 30, 2022-$1.24M–
Q1 FY2022CQ4 2021Jan 31, 2022-$1.63M–
Q4 FY2021CQ3 2021Oct 31, 2021-$937.66K–

More Zeo ScientifiX figures

See a number that looks wrong?